Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia

Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia

Abstract Background There has been an increase in incidence and prevalence of inflammatory bowel disease (IBD) outside the western countries. Treatment costs are an essential component for healthcare planning and priority setting. The utilization patterns and annual administration and cost of IBD me...

Full description

Bibliographic Details
Main Authors: Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy, Bander Balkhi
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Inflammatory bowel diseases
Crohn disease
Colitis, ulcerative
Drug utilization
Online Access:https://doi.org/10.1186/s12962-019-0194-3

Internet

https://doi.org/10.1186/s12962-019-0194-3

Similar Items